ProPhase Labs Inc (PRPH) — Strategic Asset Allocation Index
ProPhase Labs Inc (PRPH) has a Strategic Asset Allocation Index of 636.3% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $43.66 Million) total $43.66 Million, measured against net assets of $6.86 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See PRPH equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
ProPhase Labs Inc Strategic Asset Allocation Index (2000–2021)
This chart shows how ProPhase Labs Inc's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2021. As of September 2025, the index stands at 636.3%, representing strategic assets of $43.66 Million against net assets of $6.86 Million USD. For live market cap and overall valuation, see PRPH market cap overview.
Annual Strategic Asset Allocation Index for ProPhase Labs Inc (2000–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for ProPhase Labs Inc from 2000 to 2021, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See ProPhase Labs Inc (PRPH) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 17.7% | $10.35 Million | $10.35 Million | $- | $58.63 Million | ▼ -61.1 pp |
| 2020 | 78.7% | $8.31 Million | $8.31 Million | $- | $10.56 Million | ▲ +58.0 pp |
| 2019 | 20.7% | $2.33 Million | $2.33 Million | $- | $11.23 Million | ▲ +5.6 pp |
| 2018 | 15.1% | $2.50 Million | $2.50 Million | $- | $16.50 Million | ▲ +6.9 pp |
| 2017 | 8.3% | $2.74 Million | $2.74 Million | $- | $33.09 Million | ▼ -45.0 pp |
| 2016 | 53.3% | $3.17 Million | $3.17 Million | $- | $5.96 Million | ▲ +19.8 pp |
| 2015 | 33.4% | $2.95 Million | $2.95 Million | $- | $8.83 Million | ▲ +9.2 pp |
| 2014 | 24.3% | $2.60 Million | $2.60 Million | $- | $10.72 Million | ▲ +3.9 pp |
| 2013 | 20.4% | $2.56 Million | $2.56 Million | $- | $12.60 Million | ▼ -0.3 pp |
| 2012 | 20.7% | $2.37 Million | $2.37 Million | $- | $11.45 Million | ▲ +0.1 pp |
| 2011 | 20.6% | $2.31 Million | $2.31 Million | $- | $11.23 Million | ▲ +3.0 pp |
| 2010 | 17.5% | $2.36 Million | $2.36 Million | $- | $13.46 Million | ▼ -0.7 pp |
| 2009 | 18.3% | $2.57 Million | $2.57 Million | $- | $14.06 Million | ▼ -2.3 pp |
| 2008 | 20.6% | $3.67 Million | $3.67 Million | $- | $17.77 Million | ▲ +1.9 pp |
| 2007 | 18.7% | $4.36 Million | $4.36 Million | $- | $23.30 Million | ▼ -0.2 pp |
| 2006 | 18.9% | $4.84 Million | $4.84 Million | $- | $25.59 Million | ▼ -3.1 pp |
| 2005 | 22.0% | $5.59 Million | $5.59 Million | $- | $25.37 Million | ▼ -7.5 pp |
| 2004 | 29.5% | $6.47 Million | $6.47 Million | $- | $21.96 Million | ▲ +17.9 pp |
| 2003 | 11.6% | $2.42 Million | $2.42 Million | $- | $20.79 Million | ▼ -1.1 pp |
| 2002 | 12.7% | $2.34 Million | $2.34 Million | $- | $18.42 Million | ▲ +2.3 pp |
| 2001 | 10.4% | $2.20 Million | $2.20 Million | $- | $21.20 Million | ▲ +0.3 pp |
| 2000 | 10.1% | $2.14 Million | $2.14 Million | $- | $21.21 Million | — |